Avita Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 05, 2024

 

 

AVITA Medical, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware			001-39059	85-1021707
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
28159 Avenue Stanford Suite 220
Valencia, California				91355
(Address of Principal Executive Offices)				(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 661 367-9170

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		RCEL		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

---

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

AVITA Medical, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (“Annual Meeting”) virtually on June 5, 2024 (being June 6, 2024 in Australia).

 

Director and Officer Equity Awards

 

At the Annual Meeting, the Company’s stockholders approved grants of options and restricted stock units to the Company’s non-executive directors and a grant of options to the Company’s Chief Executive Officer. The grants are summarized in Item 5.07 below and in Proposals 3 through 8 (with respect to the non-executive directors) and Proposal 9 (with respect to the Chief Executive Officer) in the Company’s Proxy Statement for the Annual Meeting as filed with the Securities and Exchange Commission on April 23, 2024 (the "Proxy Statement”). The terms and conditions of such grants of options and restricted stock units are described in the Proxy Statement, which disclosure is incorporated by reference into this Item 5.02.

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual Meeting, the Company’s stockholders voted on the proposals summarized in the Proxy Statement as set forth below:

 

 

Name	Votes For			Votes Withheld			Broker Non-Votes
Mr. Louis Panaccio		9,639,179			3,437,336			2,141,804
Mr. James Corbett		12,007,045			1,243,405			2,141,804
Mr. Jeremy Curnock Cook		12,084,039			1,165,850			2,141,804
Professor Suzanne Crowe		12,341,978			908,472			2,141,804
Ms. Jan Stern Reed		11,611,092			1,635,332			2,141,804
Mr. Robert McNamara		12,261,891			988,559			2,141,804
Mr. Cary Vance		12,261,730			988,720			2,141,804

 

 

Votes For			Votes Against			Abstentions			Broker Non-Votes
	14,794,234			206,185			366,332			-

 

 

	Votes For			Votes Against			Abstentions			Broker Non-Votes
Mr. Louis Panaccio		10,834,366			1,947,210			446,306			2,138,869
Professor Suzanne Crowe		10,848,440			1,915,747			463,695			2,138,869
Mr. Jeremy Curnock Cook		10,834,337			1,948,061			445,484			2,138,869
Ms. Jan Stern Reed		10,696,549			2,082,094			449,239			2,138,869
Mr. Robert McNamara		10,837,227			1,935,886			454,769			2,138,869
Mr. Cary Vance		10,843,117			1,935,084			449,681			2,138,869

 

 

Votes For			Votes Against			Abstentions			Broker Non-Votes
	10,040,922			2,759,325			427,635			2,138,869

---

 

Votes For			Votes Against			Abstentions			Broker Non-Votes
	10,269,125			2,296,661			662,096			2,138,869

 

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			AVITA Medical, Inc.
Date:	June 6, 2024	By:	/s/ Donna Shiroma
			Donna Shiroma General Counsel

 

---